Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt
Open Access
- 28 November 2025
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 63 (7) , 967-978
Abstract
Objectives: Transjugular intrahepatic portosystemic shunt (TIPS) placement effectively decreases portal pressure in patients with decompensated cirrhosis. However, many patients develop hepatic encephalopathy (HE) post‐TIPS. We investigated the relation between the presence of Diabetes Mellitus (DM) and the occurrence of HE following TIPS placement in patients with cirrhosis. Methods: In this retrospective cohort study all patients with cirrhosis who received a TIPS from 2007 through 2021 were included. Baseline characteristics and decompensating events including hospital admission for HE were recorded. In cases where hospital admission was required, HE was considered severe. Results: In total, 325 patients were included and 113 (34.8%) had DM at the time of TIPS placement. One hundred and fifty‐one patients developed HE of whom 86 (57.0%) were hospitalised. The cumulative 6‐month incidences of HE and severe HE were 45.2% (95% CI 39.5–51.8) and 25.1% (95% CI 20.2–31.3), respectively. Multivariable Cox regression with competing risk analyses demonstrated that DM was independently associated with the risk of both HE (aHR 1.56, 95% CI 1.08–2.26, p = 0.018) and severe HE (aHR 1.76, 95% CI 1.07–2.90, p = 0.026). These associations were independent of the relation between HE and age (aHR 1.03, 95% CI 1.01–1.05, p < 0.001) or MELD‐Na score (aHR 1.07, 95% CI 1.03–1.10, p < 0.001). Conclusions: This study highlights the high incidence of HE following TIPS and shows that DM is a significant and independent risk factor for the development of HE. Given the increase in patients with metabolic dysfunction‐associated liver cirrhosis and DM, this study offers additional insights into the balance of risks and benefits associated with TIPS placement.Keywords
This publication has 37 references indexed in Scilit:
- North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal HypertensionClinical Gastroenterology and Hepatology, 2022
- Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and ManagementCardioVascular and Interventional Radiology, 2022
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Predictors of Occurrence and Risk of Hepatic Encephalopathy After TIPS Creation: A 15-Year ExperienceCardioVascular and Interventional Radiology, 2020
- Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β‐blocker for prevention of variceal rebleedingHepatology, 2015
- A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2015
- Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical OutcomesDigestive Diseases and Sciences, 2014
- Role of diabetes mellitus on hepatic encephalopathyMetabolic Brain Disease, 2012
- Ammonia and the Neutrophil in the Pathogenesis of Hepatic Encephalopathy in CirrhosisHepatology, 2010
- Association Between Small Intestinal Bacterial Overgrowth and Peripheral Bacterial DNA in Cirrhotic PatientsDigestive Diseases and Sciences, 2009